{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:15:18Z","timestamp":1778868918411,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jprasurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bjps.2022.04.013","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:44:21Z","timestamp":1650595461000},"page":"2650-2657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-4319","authenticated-orcid":false,"given":"Kevin M.","family":"Klifto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-9488","authenticated-orcid":false,"given":"David S.","family":"Ruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail K.","family":"Mithani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler S.","family":"Pidgeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Klifto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjps.2022.04.013_bib0001","unstructured":"U.S. Department of Health & Human Services, Food and Drug Administration. FDA: possible fracture risk with high dose, long-term use of proton pump inhibitors. https:\/\/wayback.archive-it.org\/7993\/20170112031951\/ http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2010\/ucm213377.htm. Updated 04\/23\/2013. Accessed January 1, 2020."},{"issue":"1","key":"10.1016\/j.bjps.2022.04.013_bib0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.gastro.2010.03.055","article-title":"Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients","volume":"139","author":"Corley","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bjps.2022.04.013_bib0003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the women's health initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.bjps.2022.04.013_bib0004","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.28.8.951","article-title":"Proton pump inhibitor use and risk of hip fractures in patients without major risk factors","volume":"28","author":"Kaye","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.bjps.2022.04.013_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.bjps.2022.04.013_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"24","key":"10.1016\/j.bjps.2022.04.013_bib0007","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bjps.2022.04.013_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","article-title":"Acid-suppressive medications and risk of bone loss and fracture in older adults","volume":"83","author":"Yu","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bjps.2022.04.013_bib0009","unstructured":"U.S. Department of Health & Human Services, Food and Drug Administration. FDA drug safety communication: possible increased risk of fractures of the hip, wrist and spine with the use of proton pump inhibitors. https:\/\/wayback.archive-it.org\/7993\/20170112003843\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsand-Providers\/ucm213206.htm. Updated 03\/23\/2016. Accessed January 1, 2020."},{"issue":"1","key":"10.1016\/j.bjps.2022.04.013_bib0010","article-title":"Proton pump inhibitors and the risk for fracture at specific sites: data mining of the FDA adverse event reporting system","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep."},{"issue":"3","key":"10.1016\/j.bjps.2022.04.013_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11005\/jbm.2018.25.3.141","article-title":"Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis","volume":"25","author":"Nassar","year":"2018","journal-title":"J Bone Metab"},{"issue":"5","key":"10.1016\/j.bjps.2022.04.013_bib0012","first-page":"347","article-title":"Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa","volume":"89","author":"Arroyo Villarino","year":"1997","journal-title":"Rev Esp Enferm Dig"},{"issue":"2","key":"10.1016\/j.bjps.2022.04.013_bib0013","first-page":"123","article-title":"Effects of helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells","volume":"25","author":"Bektas","year":"2012","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"10.1016\/j.bjps.2022.04.013_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(00)00080-7","article-title":"Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (ws\/ws) rats","volume":"394","author":"Nakamura","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.bjps.2022.04.013_bib0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00042737-200505000-00013","article-title":"Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa","volume":"17","author":"Rindi","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2\u20133","key":"10.1016\/j.bjps.2022.04.013_bib0016","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2003.09.011","article-title":"Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells","volume":"481","author":"Yokota","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.bjps.2022.04.013_bib0017","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2353\/ajpath.2009.080871","article-title":"Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts","volume":"174","author":"Biosse-Duplan","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.bjps.2022.04.013_bib0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1258\/0007142991902501","article-title":"Bone health: the role of micronutrients","volume":"55","author":"New","year":"1999","journal-title":"Br Med Bull"},{"issue":"7","key":"10.1016\/j.bjps.2022.04.013_bib0019","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.bjps.2022.04.013_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/bulm.1999.0146","article-title":"Parathyroid hormone temporal effects on bone formation and resorption","volume":"62","author":"Kroll","year":"2000","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.bjps.2022.04.013_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000486060","article-title":"Physiology of the calcium-parathyroid hormone-vitamin D axis","volume":"50","author":"Goltzman","year":"2018","journal-title":"Front Horm Res"},{"issue":"4","key":"10.1016\/j.bjps.2022.04.013_bib0022","first-page":"257","article-title":"Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption","volume":"12","author":"Rude","year":"1999","journal-title":"Magnes Res"},{"issue":"6","key":"10.1016\/j.bjps.2022.04.013_bib0023","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000854","article-title":"World gastroenterology organisation global guidelines: GERD global perspective on gastroesophageal reflux disease","volume":"51","author":"Hunt","year":"2017","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681522001978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681522001978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:49:18Z","timestamp":1761684558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681522001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1748681522001978"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2022.04.013","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Plastic, Reconstructive & Aesthetic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjps.2022.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}